MAGL-IN-15
MAGL-IN-15 (Compound 6) is a MAGL inhibitor that can be used in the research of diseases and disorders related to the regulation of endocannabinoid system signaling activities[1].
Product Specifications
CAS Number
[2770967-08-1]
UNSPSC
12352005
Target
MAGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/magl-in-15.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H]1CC12CCN(C(OC(C(F)(F)F)C(F)(F)F)=O)CC2)NC3=CC=CN=N3
Molecular Formula
C16H16F6N4O3
Molecular Weight
426.31
References & Citations
[1]John J.M. Wiener, et al. Magl inhibitors. U.S. US20240018120A1. 2024-01-18
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1038748-01 0.02 mg (E-Coli)
Recombinant Escherichia coli Peptide chain release factor 2 (prfB)
Ask
View Details 
MBS1038748-02 0.02 mg (Yeast)
Recombinant Escherichia coli Peptide chain release factor 2 (prfB)
Ask
View Details MBS1038748-03 0.1 mg (E-Coli)
Recombinant Escherichia coli Peptide chain release factor 2 (prfB)
Ask
View Details MBS1038748-04 0.1 mg (Yeast)
Recombinant Escherichia coli Peptide chain release factor 2 (prfB)
Ask
View Details 
MBS1038748-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli Peptide chain release factor 2 (prfB)
Ask
View Details MBS1038748-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli Peptide chain release factor 2 (prfB)
Ask
View Details